Relief Therapeutics   Report issue

For profit Phase 2
Founded: Geneva Switzerland (2016)

Organization Overview

First Clinical Trial
2020
NCT04311697
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Relief Therapeutics Holding SA